Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · S-8

Standard BioTools Inc.

LABNASDAQEQUITYCurrent

SEC Filing

Filed Aug 5, 2026Accepted Aug 5, 2026, 5:00 PM EDTCIK 1162194Accession 0001104659-26-091220
Share

Company context

Standard BioTools, Inc. (NASDAQ: LAB), is committed to setting the new standard in the life science tools industry through strategic consolidation, best-in-class operations and a world-class management team. The Company's established portfolio includes essential, standardized next-generation solutions designed to help biomedical researchers develop better therapeutics faster. For Research Use Only. Not for use in diagnostic procedures.

Current securities

Historical securities (1)

Recent company filings

  1. S-4/A filingSep 9, 2026
  2. 4 filingAug 24, 2026
  3. SCHEDULE 13G/A filingAug 14, 2026
  4. SCHEDULE 13G filingAug 14, 2026
  5. S-8 filingAug 5, 2026

As-filed source

Primary evidence